Neogen (NEOG) EBITDA (2010 - 2026)

Neogen has reported EBITDA for 17 years, with the latest figure at $3.1 million in Q2 2026.

• On a quarterly basis, EBITDA rose 100.51% year-over-year to $3.1 million in Q2 2026; TTM through May 2026 was -$21.7 million, a 97.96% increase from a year earlier, with the FY2026 full-year figure at -$21.6 million, up 97.96% from the prior year.
• EBITDA was $3.1 million for Q2 2026 at Neogen, up from -$3.3 million in the prior quarter.
• The five-year high for EBITDA was $23.4 million in Q2 2023, with the low at -$611.2 million in Q2 2025.
• Average EBITDA over 5 years is -$53.5 million, with a median of $5.7 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: EBITDA soared 288.94% in 2023, then slumped 4809.87% in 2025.
• Over 5 years, EBITDA stood at -$7.7 million in 2022, then jumped by 288.94% to $14.5 million in 2023, then sank by 3262.7% to -$457.5 million in 2024, then jumped by 98.82% to -$5.4 million in 2025, then soared by 157.65% to $3.1 million in 2026.
• The last three EBITDA figures came in at $3.1 million (Q2 2026), -$3.3 million (Q1 2026), and -$5.4 million (Q4 2025), per Business Quant data.